- Advertisement -spot_img
Monday, December 30, 2024

Top 10 Pharma & Lifesciences Solution Providers 2022

Life sciences companies face distinct challenges with their very visible role in drug pricing and access to medicines, and the pandemic only underscored this focus. Even during these unprecedented times over the last two years, many life sciences organizations have witnessed a scientific breakthrough. Shifts to more data-driven approaches across the value chain, greater collaborations, digital transformation, and the advancing CEO priorities are driving the change. A new bar has been set and companies are now willing to move beyond convention to solve the toughest challenges and stand to reap the biggest benefits.

As the life sciences industry’s research body becomes increasingly expansive, many experts discover that some conditions are inherited through genetic coding. This implies that healthcare can be more customized based on DNA information or other genomic features. This ushers a new era of personalized medicines and healthcare procedures.

The 2022 Global Life Sciences edition focuses on the current state of the sector, explores seven trends shaping the industry and prepares stakeholders to take advantage of the many opportunities the pandemic has surfaced and accelerated. In the year ahead, forward-looking companies will adopt a think-digital-to-be-digital mindset and consider how these technologies can augment human capabilities and update execution of processes.

As the industry is noisy, this special edition features some of the most innovative pharma and life science solution providers. The below list of companies are selected by our team of CEOs, CIOs and healthcare experts to help our readers get a clearer view of the industry.

AscellaHealth

Management:

Dea Belazi

Designation:

President & CEO

Headquarters:

Berwyn, PA

Website:

ascellahealth.com

AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving payers, providers, life sciences and patients, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex, chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies.

Exceed Orphan

Management:

Jiri Hermanek

Designation:

Founding Partner, CEO & GM

Headquarters:

Prague, Czech Republic

Website:

exceedorphan.com

As a single partner, ExCEEd Orphan offers services for all needed aspects of launching and marketing rare disease medications from market assessment through KOL ngagement, market access negotiations, medical education and marketing up to distribution.

MetaCell

Management:

Stephen Larson

Designation:

CEO

Headquarters:

Boston, MA

Website:

metacell.us

MetaCell is a life science-focused software company composed of scientists and software engineers with deep domain expertise in computational neuroscience, molecular biology, data science, and enterprise-grade online software development.

Navitas Lifesciences

Management:

Srinivasan HR

Designation:

CEO

Headquarters:

Princeton, NJ

Website:

navitaslifesciences.com

Navitas Life Sciences delivers platform-driven full-service Clinical, Regulatory, and Safety solutions and services. Navitas operates across North America, Europe, Asia Pacific, and Latin America. Navitas brings together the capabilities of a full-service CRO, a technology-led life sciences services provider, and expertise in analytics and data sciences to address critical challenges and drive outcomes for life sciences.

PointClickCare

Management:

Jeff Wessinger

Designation:

VP & GM of Life Sciences

Headquarters:

Mississauga, ON

Website:

pointclickcare.com

With close to 200 million patient records, PointClickCare is uniquely positioned to provide life sciences companies with outcomes-based evidence - such as, longitudinal patient records, daily health outcomes, monthly minimum dataset assessments, and more.

RareCyte

Management:

Joe Victor

Designation:

President & CEO

Headquarters:

Seattle, WA

Website:

rarecyte.com

Leaders across Research, Translational Medicine and the Clinic rely on RareCyte as a one-stop resource for Spatial Biology and Liquid Biopsy solutions. Headquartered in Seattle, WA, RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy.

Strateos

Management:

MARK FISCHER-COLBRIE

Designation:

President & CEO

Headquarters:

Menlo Park, CA

Website:

strateos.com

Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Our mission is to create new knowledge driven by data, computation, automation, and high-throughput robotics with the goal of fundamentally advancing the life sciences. The Strateos Automation-as-a-Service Platform helps scientists more efficiently and reproducibly design, run, and analyze experiments to achieve new and faster scientific discoveries.

Tact.ai

Management:

Chuck Ganapathi

Designation:

Founder & CEO

Headquarters:

Sunnyvale, CA

Website:

tact.ai

Tact.ai is on a mission to help life science organizations nurture meaningful customer engagement through their human-friendly software. Their AI-powered engagement platform empowers field teams to work with their customers in new ways to drive better outcomes. Tact.ai is headquartered in Silicon Valley and is backed by some of the world’s leading firms in venture capital, technology, and healthcare and life sciences, including Microsoft’s venture fund M12, Salesforce Ventures, Novartis, Lilly and McKesson Ventures.

Tenthpin Management Consultants AG

Management:

Jürgen Bauer

Designation:

Partner & Chairman of the Executive Board

Headquarters:

Basel, CH

Website:

tenthpin.com

Tenthpin is a globally leading business and technology consultancy for the life sciences industry. They create digital impact and transformational change by combining our industry, process, and information technology expertise. Their clients span all industry segments and sizes, from medtech to animal health. from small clinical research to big pharma. Their clients trust in the independent, unbiased advise and services.

Zenith Technologies

Management:

Joe Haugh

Designation:

CEO

Headquarters:

Cork, Ireland

Website:

zenithtechnologies.com

Zenith Technologies, a Cognizant Company transforms Life Sciences manufacturing focusing on delivering speed to value now. They provide scalable Information Technologies (IT) & Operational Technologies (OT) end-to-end smart factory solutions, from conception, through maintenance and completion, across the entire manufacturing lifecycle.

Translate »